Abstract:Background Coronary artery calcification (CAC) is common in end-stage renal disease (ESRD) patients, and the extent of CAC is closely related to cardiovascular outcomes in ESRD patients. Cartilage oligomeric matrix protein (COMP), as a component of the vascular matrix, has been found to be an inhibitor of arterial calcification in basic studies. However, there is no clinical research on the correlation between COMP and CAC in maintenance hemodialysis (MHD) patients. The aim of this study was to explore the relationship between serum COMP levels and CAC and cardiovascular events in MHD patients. Methods Serum COMP levels were compared between 54 MHD patients and 66 healthy people. MHD patients were then divided into three groups according to the tertiles of the concentration of COMP level and were followed up for major adverse cardiac events (MACEs), which were defined as a combined end point of new onset angina pectoris, nonfatal myocardial infarction, heart failure, coronary artery revascularization, hospitalization due to angina pectoris and all-cause deaths. The CAC score was calculated based on computed tomography scans. Results The serum COMP level in MHD patients was significantly higher than that in the general population [984.23 (248.43-1902.61) ng/mL vs. 219.01 (97.26-821.92) ng/mL, P < 0.01]. Serum COMP levels were positively correlated with CAC (r = 0.313, P = 0.021) and serum parathyroid hormone in MHD patients (r = 0.359, P < 0.01). Linear regression suggested that after adjusting for age, fasting blood glucose (Glu) and glycosylated hemoglobin (HbAlc), CAC score was an independent predictor in the final model for COMP level (beta = 0.424, t = 3.130, P < 0.01). The receiver operating characteristic (ROC) curve showed that COMP >= 994 mg/mL had 68.0% sensitivity and 72.4% specificity for the prediction of severe CAC [area under the curve (AUC): 0.674, P = 0.030, 95% CI: 0.526-0.882]. After a median follow-up of 16 months (8-24 months), there was no difference in the incidence rate of MACEs between the upper, middle and lower serum COMP groups. Conclusions Our study found that MHD patients have higher levels of circulating COMP than controls. The serum COMP level is positively correlated with CAC score and could be used as a biomarker of severe CAC in MHD patients. However, there is no obvious correlation between serum COMP levels and the incidence of cardiovascular events.

Elevated Serum Cartilage Oligomeric Matrix Protein and the Metalloproteinase-Adamts7 Levels Are Associated with Vascular Calcification in Maintenance Hemodialysis Patients.

Association Between Serum Cartilage Oligomeric Matrix Protein and Coronary Artery Calcification in Maintenance Hemodialysis Patients

The Correlation of Plasma Cartilage Oligomeric Matrix Protein with Vascular Calcification and Cardiovascular Events in Hemodialysis Patients

Altered Serum Level of Cartilage Oligomeric Matrix Protein and Its Association with Coronary Calcification in Patients with Coronary Heart Disease

Upregulation of a Disintegrin and Metalloproteinase with Thrombospondin Motifs-7 by Mir-29 Repression Mediates Vascular Smooth Muscle Calcification.

Cartilage Oligomeric Matrix Protein Inhibits Vascular Smooth Muscle Calcification by Interacting with Bone Morphogenetic Protein-2.

Diagnostic value of serum COMP and ADAMTS7 for intervertebral disc degeneration

Compensatory Elevated Serum Intermedin Levels Are Associated with Increased Vascular Calcification in Hemodialysis Patients

Cartilage Oligomeric Matrix Protein: Matricellular And Matricrine Signaling In Cardiovascular Homeostasis And Disease

Serum Alkaline Phosphatase Level Predicts Cardiac Valve Calcification in Maintenance Hemodialysis Patients

Interrelations among Vascular Calcification, Bone Density, Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor Kb Ligand in Hemodialysis Patients

Progression of cardiovascular calcification in hemodialysis patients

Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis

The significance of serum SLC7A11 levels in the occurrence of vascular calcification in maintenance peritoneal dialysis patients

Correlation between serum cartilage oligomeric matrix protein and major adverse cardiovascular events within 30 days in patients with acute coronary syndrome

Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis

Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease.

Plasma Complement Protein C3a Level Was Associated with Abdominal Aortic Calcification in Patients on Hemodialysis

Association of Serum Phosphorus Variability with Coronary Artery Calcification among Hemodialysis Patients

Effect of parathyroid hormone on myocardial damage,cardiac structure and function in maintenance hemodialysis patients

Relationship of Srankl Level and Vascular Calcification Score to Cardiovascular Events in Maintenance Hemodialysis Patients